Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Global Market Report 2026

Description

Next-generation sequencing (NGS)-based molecular diagnostics is a technology-driven approach that uses high-throughput sequencing to analyze genetic material with precision and speed. It enables detection of genetic variations, mutations, and disease markers at the molecular level, providing detailed insights into the genetic basis of health and disease. This approach supports precise, data-driven diagnostics by combining sequencing technologies with advanced bioinformatics.

The primary types of NGS-based molecular diagnostics include instruments, reagents and consumables, software and services, panels and assays, and sample preparation kits. NGS instruments are the hardware platforms, such as sequencers and automation workstations, used to perform high-throughput DNA/RNA sequencing. Applications include microbiology, infectious diseases, oncology, genetic testing, and other areas. End users include research centers, academic institutions, hospitals, clinical laboratories, and other organizations.

Tariffs have influenced the NGS-based molecular diagnostics market by raising the cost of imported instruments, sequencing kits, and bioinformatics software. Hospitals, research labs, and diagnostic centers are most affected, particularly in Asia-Pacific and Europe. Segments like high-throughput sequencers and library preparation kits face increased costs. Positive outcomes include promotion of local manufacturing and domestic software development, which enhances supply chain resilience and innovation.

The next-generation sequencing (ngs)-based molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides next-generation sequencing (ngs)-based molecular diagnostics market statistics, including next-generation sequencing (ngs)-based molecular diagnostics industry global market size, regional shares, competitors with a next-generation sequencing (ngs)-based molecular diagnostics market share, detailed next-generation sequencing (ngs)-based molecular diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the next-generation sequencing (ngs)-based molecular diagnostics industry. This next-generation sequencing (ngs)-based molecular diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The next-generation sequencing (ngs)-based molecular diagnostics market size has grown strongly in recent years. It will grow from $2.26 billion in 2025 to $2.43 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to growth in genetic disorder testing, development of high-throughput sequencing, rising awareness of molecular diagnostics, adoption in clinical labs, technological improvements in sequencing reagents.

The next-generation sequencing (ngs)-based molecular diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.23 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to integration of ai and machine learning in diagnostics, expansion of cloud-based genomic platforms, development of portable and point-of-care sequencing devices, rise in personalized medicine applications, collaborations between diagnostics and biotech firms. Major trends in the forecast period include AI-assisted molecular diagnostics, cloud genomic analysis platforms, portable sequencing devices, integration of bioinformatics pipelines, rapid disease marker detection.

The rising incidence of infectious diseases is expected to drive growth in the next-generation sequencing (NGS)-based molecular diagnostics market in the coming years. Infectious diseases are illnesses caused by microorganisms such as bacteria, viruses, fungi, or parasites that invade and multiply within the body, disrupting normal functions. Increasing global travel and migration contribute to the spread of pathogens across regions and borders, fueling the rise in infectious disease cases. NGS-based molecular diagnostics aids in detecting these diseases by offering comprehensive and precise analysis of pathogens, enabling simultaneous identification of multiple microorganisms, which shortens diagnostic time and improves treatment accuracy and patient care. For example, in February 2024, the UK Health Security Agency reported that tuberculosis cases in England increased by 10.7%, rising from 4,380 in 2022 to 4,850 in 2023. Consequently, the growing incidence of infectious diseases is propelling the demand for NGS-based molecular diagnostics.

Major companies operating in the next-generation sequencing (NGS)-based molecular diagnostics market are concentrating on developing advanced NGS-based panels to improve the accuracy, accessibility, and efficiency of genetic testing. NGS panels are targeted collections of genes or genomic regions analyzed simultaneously using NGS technology to identify clinically relevant mutations, enabling faster and more precise molecular diagnostics. For example, in April 2024, Pillar Biosciences, a US-based diagnostics company, received FDA approval for its oncoReveal CDx pan-cancer solid tumor IVD kit, which examines 22 clinically relevant genes in a single multiplex reaction. Designed for use with Illumina's MiSeq Dx system, the panel offers a sample-to-report time of around 48 hours and can process up to 46 clinical samples per run. OncoReveal CDx includes companion diagnostic claims for KRAS (for EGFR-targeted therapy in colorectal cancer) and EGFR (for TKI therapy in non-small-cell lung cancer), allowing more comprehensive and efficient detection of actionable genomic alterations to enhance clinical decision-making.

In January 2023, QIAGEN NV, a molecular diagnostics and life sciences company based in Germany, acquired Verogen Inc. for an undisclosed sum. This acquisition aims to enhance QIAGEN's leadership in human identification and forensic genomics by integrating Verogen's specialized NGS technologies into its broader molecular diagnostics portfolio. This expansion strengthens QIAGEN's presence in public sector forensics and private sector applications such as genetic genealogy. Verogen Inc. is a US-based company specializing in NGS solutions for forensic genomics.

Major companies operating in the next-generation sequencing (ngs)-based molecular diagnostics market are Thermo Fisher Scientific, Siemens Healthineers AG, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Amoy Diagnostics Co. Ltd., Tempus Labs Inc., Myriad Genetics Inc., Epigenomics AG, Precision for Medicine Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., Caris Life Sciences Inc., Foundation Medicine Inc., Oxford Nanopore Technologies Ltd., Freenome Inc., Burning Rock Biotech, Element Biosciences Inc., Asuragen Inc., Bionano Genomics Inc., Genomic Health Inc., TATAA Biocenter AB

North America was the largest region in the next-generation sequencing (NGS)-based molecular diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next-generation sequencing (ngs)-based molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the next-generation sequencing (ngs)-based molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The next-generation sequencing (NGS)-based molecular diagnostics market includes revenues earned by entities by providing services, such as clinical genomic testing, cancer genomic profiling, infectious disease detection, liquid biopsy testing, and pharmacogenomics testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The next-generation sequencing (NGS)-based molecular diagnostics market also includes sales of tumor mutation panels, carrier screening kits, drug response panels, companion diagnostic kits, and whole-genome metagenomics kits. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Next-Generation Sequencing (NGS)-Based Molecular Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses next-generation sequencing (ngs)-based molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for next-generation sequencing (ngs)-based molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The next-generation sequencing (ngs)-based molecular diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Type: Instruments; Reagents And Consumables; Software And Services; Panels And Assays; Sample Preparation Kits
2) By Application: Microbiology; Infectious Diseases; Oncology; Genetic Tests; Other Applications
3) By End User: Research Centers And Academics; Hospitals And Clinical Laboratories; Other End Users
Subsegments:
1) By Instruments: Benchtop Sequencers; High-Throughput Sequencers; Portable Or Handheld Sequencers; Clinical Or Diagnostic Sequencers; Automated Library Preparation Systems; Data Analysis And Bioinformatics Hardware
2) By Reagents And Consumables: Sequencing Reagents And Kits; Library Preparation Reagents; Target Enrichment Reagents; Amplification Reagents; Sequencing Flow Cells And Chips; Deoxyribonucleic Acid (DNA) Or Ribonucleic Acid (RNA) Extraction Reagents; Quality Control Reagents
3) By Software And Services: Data Analysis Software; Bioinformatics Pipelines; Cloud-Based Genomic Platforms; Clinical Interpretation Tools; Data Storage And Management Services; Custom Bioinformatics Services; Genomic Database Services
4) By Panels And Assays: Oncology Panels; Infectious Disease Panels; Carrier Screening Panels; Reproductive Health Panels; Rare Disease Or Genetic Disorder Panels; Pharmacogenomics Panels; Whole-Exome Or Whole-Genome Assays
5) By Sample Preparation Kits: Deoxyribonucleic Acid (DNA) Extraction Kits; Ribonucleic Acid (RNA) Extraction Kits; Library Preparation Kits; Target Enrichment Kits; Amplification And Cleanup Kits; Single-Cell Preparation Kits; Low-Input Or Degraded Sample Kits
Companies Mentioned: Thermo Fisher Scientific; Siemens Healthineers AG; Agilent Technologies Inc.; Illumina Inc.; PerkinElmer Inc.; Bio-Rad Laboratories Inc.; Qiagen N.V.; Amoy Diagnostics Co. Ltd.; Tempus Labs Inc.; Myriad Genetics Inc.; Epigenomics AG; Precision for Medicine Inc.; Invitae Corporation; NeoGenomics Laboratories Inc.; Guardant Health Inc.; Caris Life Sciences Inc.; Foundation Medicine Inc.; Oxford Nanopore Technologies Ltd.; Freenome Inc.; Burning Rock Biotech; Element Biosciences Inc.; Asuragen Inc.; Bionano Genomics Inc.; Genomic Health Inc.; TATAA Biocenter AB
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: ME5MNGSN04_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Artificial Intelligence & Autonomous Intelligence
- 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.4 Industry 4.0 & Intelligent Manufacturing
- 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
- 4.2.1 Ai-Assisted Molecular Diagnostics
- 4.2.2 Cloud Genomic Analysis Platforms
- 4.2.3 Portable Sequencing Devices
- 4.2.4 Integration Of Bioinformatics Pipelines
- 4.2.5 Rapid Disease Marker Detection

5. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Analysis Of End Use Industries

5.1 Research Centers And Academic Institutes
5.2 Hospitals And Clinical Laboratories
5.3 Biopharmaceutical Companies
5.4 Genetic Testing Laboratories
5.5 Contract Research Organizations (Cros)

6. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Size, Comparisons And Growth Rate Analysis
7.3. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Segmentation

9.1. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Instruments, Reagents And Consumables, Software And Services, Panels And Assays, Sample Preparation Kits
9.2. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Microbiology, Infectious Diseases, Oncology, Genetic Tests, Other Applications
9.3. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Research Centers And Academics, Hospitals And Clinical Laboratories, Other End Users
9.4. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Benchtop Sequencers, High-Throughput Sequencers, Portable Or Handheld Sequencers, Clinical Or Diagnostic Sequencers, Automated Library Preparation Systems, Data Analysis And Bioinformatics Hardware
9.5. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Sequencing Reagents And Kits, Library Preparation Reagents, Target Enrichment Reagents, Amplification Reagents, Sequencing Flow Cells And Chips, Deoxyribonucleic Acid (DNA) Or Ribonucleic Acid (RNA) Extraction Reagents, Quality Control Reagents
9.6. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Data Analysis Software, Bioinformatics Pipelines, Cloud-Based Genomic Platforms, Clinical Interpretation Tools, Data Storage And Management Services, Custom Bioinformatics Services, Genomic Database Services
9.7. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Sub-Segmentation Of Panels And Assays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oncology Panels, Infectious Disease Panels, Carrier Screening Panels, Reproductive Health Panels, Rare Disease Or Genetic Disorder Panels, Pharmacogenomics Panels, Whole-Exome Or Whole-Genome Assays
9.8. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Sub-Segmentation Of Sample Preparation Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Deoxyribonucleic Acid (DNA) Extraction Kits, Ribonucleic Acid (RNA) Extraction Kits, Library Preparation Kits, Target Enrichment Kits, Amplification And Cleanup Kits, Single-Cell Preparation Kits, Low-Input Or Degraded Sample Kits

10. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Regional And Country Analysis

10.1. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

11.1. Asia-Pacific Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

12.1. China Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

13.1. India Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

14.1. Japan Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

15.1. Australia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

16.1. Indonesia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

17.1. South Korea Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

18.1. Taiwan Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

19.1. South East Asia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

20.1. Western Europe Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

21.1. UK Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

22.1. Germany Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

23.1. France Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

24.1. Italy Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

25.1. Spain Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

26.1. Eastern Europe Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

27.1. Russia Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

28.1. North America Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

29.1. USA Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

30.1. Canada Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

31.1. South America Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

32.1. Brazil Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

33.1. Middle East Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

34.1. Africa Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market, Segmentation By Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Regulatory and Investment Landscape

36. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Competitive Landscape And Company Profiles

36.1. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Company Profiles
- 36.3.1. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Other Major And Innovative Companies

Bio-Rad Laboratories Inc., Qiagen N.V., Amoy Diagnostics Co. Ltd., Tempus Labs Inc., Myriad Genetics Inc., Epigenomics AG, Precision for Medicine Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., Caris Life Sciences Inc., Foundation Medicine Inc., Oxford Nanopore Technologies Ltd., Freenome Inc., Burning Rock Biotech

38. Global Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market

40. Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market High Potential Countries, Segments and Strategies

40.1 Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market In 2030 - Countries Offering Most New Opportunities
40.2 Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market In 2030 - Segments Offering Most New Opportunities
40.3 Next-Generation Sequencing (Ngs)-Based Molecular Diagnostics Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer